Effects of Proton Pump Inhibitors SCH 28080, SPI-447 and Rebeprazole on the Gastric Phospholipid Flippase Activity.

DOI Web Site 16 References
  • Morii Magotoshi
    Department of Pharmaceutical Physiology, Faculty of Pharmaceutical Sciences, Toyama Medical and Pharmaceutical University
  • Wanajo Isao
    Department of Pharmaceutical Physiology, Faculty of Pharmaceutical Sciences, Toyama Medical and Pharmaceutical University
  • Suzuki Hidehiro
    Department of Pharmaceutical Physiology, Faculty of Pharmaceutical Sciences, Toyama Medical and Pharmaceutical University
  • Murata Takanari
    Department of Pharmaceutical Physiology, Faculty of Pharmaceutical Sciences, Toyama Medical and Pharmaceutical University
  • Takeguchi Noriaki
    Department of Pharmaceutical Physiology, Faculty of Pharmaceutical Sciences, Toyama Medical and Pharmaceutical University

Bibliographic Information

Other Title
  • 胃リン脂質フリッパーゼ活性におよぼすプロトンポンプ阻害剤ＳＣＨ２８０８０，ＳＰＩ‐４４７，Ｒａｂｅｐｒａｚｏｌｅの影響
  • イ リン シシツ フリッパーゼ カッセイ ニ オヨボス プロトン ポンプ ソガイザイ SCH28080 SPI 447 Rabeprazole ノ エイキョウ

Search this article

Abstract

The gastric phospholipid flippase has been found in isolated gastric vesicles. Fluorescence analogues of phospholipid and endogenous phospholipids were translocated from the outer to inner leaflet of the lipid bilayer membrane of hog gastric vesicles in an ATP-dependent manner. Previously we found that the flippase activity in gastric vesicles was inhibited by a K+-competitive specific inhibitor of the gastric H+, K+-ATPase, 2-methyl-8- (phenylmethoxy) imidazo [1, 2-a] pyridine-3-acetonitoril (SCH 28080). Here, we studied effects of other gastric proton pump inhibitors on the flippase activity. We found that another K+-competitive specific inhibitor of the gastric H+, K+-ATPase, 3-amino-5-methyl-2- (2-methyl-3-thionyl) imidazo [1, 2-a] thieno [3, 2-c] pyridine (SPI-447) also inhibited the flippase activity. A substituted benzimidazole-related gastric H+, K+-ATPase inhibitor, 2- {[4- (3-methoxypropoxy) -3-methylpyridin-2-ly] methylsulfinyl}-1H-benzimidazole (rabeprazole) decreased the phospholipid flippase activity to 80.6 ± 14.8% (n = 3) of the control level whereas it decreased the proton pump K+-ATPase activity to 5.6 ± 3.4% (n = 3) of the control level. These results indicated a possibility that the phospholipid flippase activity of hog gastric vesicles is part of the H+, K+-ATPase reaction, although further studies are required to confirm this possibility.

Journal

  • MEMBRANE

    MEMBRANE 25 (6), 324-331, 2000

    THE MEMBRANE SOCIETY OF JAPAN

References(16)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top